Welcome to our dedicated page for PAYCHEX SEC filings (Ticker: PAYX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Paychex, Inc. filings document formal disclosures for its human capital management business, including quarterly operating results furnished on Form 8-K, credit facility amendments, capital-return authorizations, and governance changes involving directors and senior officers.
The company's proxy materials and annual-meeting reports address board elections, executive compensation votes, auditor ratification, committee matters, and stockholder voting outcomes. Its filings also describe common-stock repurchase authority, revolving credit facilities, covenant changes, and formal reporting for payroll, HCM, HR Solutions, PEO, ASO, benefits, retirement, and insurance services.
Paychex, Inc. (PAYX) is soliciting proxies for its 2026 Annual Meeting, asking stockholders to elect ten directors for one-year terms, approve on an advisory basis named executive officer (NEO) compensation, ratify PricewaterhouseCoopers LLP as independent auditor, and vote on a shareholder proposal to provide an attainable right to call special shareholder meetings, which the Board recommends voting against.
For fiscal 2026, Paychex reports total service revenue of $6.3 billion, up 16%, and operating income of $2.5 billion, up 14%. Diluted EPS was $4.89, a 7% increase, while operating income net of certain items was $2.6 billion, up 19%, and adjusted diluted EPS was $5.51, up 11%. The company returned $2.2 billion to stockholders through dividends and share repurchases, including a 10% increase in the quarterly dividend to $1.19 per share and repurchase of 5.6 million shares for $611.0 million.
The proxy details a pay-for-performance program with a heavy emphasis on variable and equity-based compensation. Fiscal 2026 annual cash incentive payouts were 64% of target for the CEO and other NEOs based on quantitative and qualitative goals. CEO John B. Gibson received total compensation of $10.3 million, with a large portion in performance-based RSUs and stock options, and stock ownership guidelines require the CEO to hold stock equal to six times base salary and other NEOs three times. The filing also highlights strong governance practices, including independent Board committees, a Clawback Policy, prohibitions on hedging and pledging company stock, and active shareholder engagement.
PAYCHEX INC (PAYX) major shareholder Thomas B. Golisano reported a bona fide gift of 334 shares of common stock on September 1, 2026, made from the Cynthia A. Golisano Irrevocable Trust for which he serves as trustee, as part of a quarterly trust distribution. The filing also reports that he continues to hold 35,653,923 PAYCHEX common shares directly and 37,884 shares indirectly through the trust. No Rule 10b5-1 trading plan is reported for these transactions, and the gift does not represent an open-market sale.
PAYCHEX INC executive Christopher C. Simmons reported the disposition of 130 shares of common stock on 2026-08-14 at $122.02 per share, with the footnote stating these shares were withheld to satisfy tax withholding obligations from the vesting of restricted stock units. Following this tax-withholding event, he directly holds 3,290 shares of common stock. He also reports multiple outstanding stock options over PAYX common stock, including options covering 4,391 shares at a $115.00 exercise price expiring in 2032 and 4,589 shares at a $120.86 exercise price expiring in 2033, along with several additional grants at exercise prices between $110.00 and $140.68 with expirations from 2033 to 2036.
Paychex, Inc. disclosed a planned change to its Board of Directors. On July 16, 2026, director Kara Wilson notified the Board that she will not stand for re-election at the company’s 2026 annual meeting of stockholders. Her current term will continue until that meeting.
In connection with her departure, the Board determined to reduce its size from 11 to 10 directors, effective immediately upon the expiration of Ms. Wilson’s term at the 2026 annual meeting. The company states that Ms. Wilson’s decision did not result from any disagreement regarding operations, policies, or practices.
Paychex Inc chairman and director Martin Mucci reported a bona fide gift of 9,309 shares of common stock on 2026-07-17, valued at $113.9819 per share, to The Mucci Family Foundation. After this gift, he directly holds 434,891.3318 common shares plus multiple outstanding stock option awards.
Paychex Inc. director Joseph Doody reported an internal reallocation of holdings on 2026-07-20. He transferred 164 directly held common shares to the Joseph G. Doody Revocable Living Trust, leaving 725 shares in his direct ownership and 23,922 shares held indirectly through that trust. The transfer was recorded at $0.00 per share, indicating no open-market trade.
Doody also reports indirect ownership of 1,000 Paychex shares held by the Margaret Weiss Doody Revocable Living Trust. In addition, he holds several stock options over Paychex common stock, with exercise prices between $73.53 and $140.68 and expiration dates extending from 2029 to 2035.
Paychex Sr. VP and CFO Robert L. Schrader reported selling 2,600 shares of Paychex common stock on July 20, 2026 at $115.09 per share, leaving him with 18,547 directly held shares. He also reports multiple outstanding employee stock options on Paychex common stock with exercise prices including $73.53, $112.67, $115.00, $120.86, $117.98, $121.63 and $140.68, expiring between 2030 and 2036, plus 339 shares held indirectly via a 401(k) plan.
A holder of PAYX common stock filed a notice to potentially sell 9,309 shares through Merrill Lynch, Pierce, Fenner & Smith Incorporated, with an aggregate market value of $1,061,057.32. The shares relate to earlier gift acquisitions dated in 2014 and 2015, and the approximate sale date is stated as mid-July 2026 on Nasdaq.